UK technology business Evove recently completed an equity funding round, with existing and new investors backing the business to accelerate growth.
Evove’s innovative graphene oxide coating products that reduce the cost and environmental impact of water treatment, have developed significant market traction, with a rapidly growing pipeline of opportunities across a broad range of sectors including industrial, oil & gas, food & beverage and domestic water filtration.
Chris Wyres, CEO of Evove stated “Strong market traction for our Graphene oxide coating products has enabled us to secure additional capital from investors to accelerate growth and delivery of the strong pipeline of opportunities we have generated. As part of this strategy, we will be expanding our facilities and team, ramping up marketing and business development and commercialising an exciting range of new products.”
The company will be focusing on converting a rapidly growing pipeline of opportunities, gearing the business to support partners and expedite progression through prototyping and industrial testing. Evove are currently applying their innovative technology to solve critical challenges in a broad range of water treatment processes, including desalination and the oil and gas, food and beverage and energy sectors. In each case, the proven solutions deliver enhanced operational efficiency, reducing energy costs, maintenance and chemical usage, as well as extending the lifetime of the membranes. This enables end-users to not only reduce costs, but also to minimise their environmental impact and contribute to addressing climate change.
“We’re delighted that all our current investors have recognised the excellent progress made by the company in the last 12 months and have continued to support us. It is also a pleasure to welcome our new industrial investors to Evove, which is a tremendous vote of confidence in the future of the company. The timing of this investment comes as the company has just achieved a key milestone with the signing of its first commercial licensing agreement and I look forward to an exciting future as we progress through to full scale commercialisation of the technology with our development partners.” commented Andrew Greenaway, Chairman of Evove.